Replay: Treating Adolescent Depression with DTx

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression.  Big Health, the leading provider of non-drug digital treatments for mental health, has now acquired Limbix. In addition to health care providers, SparkRx will be made available to Big Health’s employer, public sector, health systems and health plan customers, and through the company’s strategic distribution agreements with pharmacy benefit managers (PBMs), significantly increasing nationwide access.

In this episode, we cover:

Origin of the company and story behind the name 'Limbix'

The funding journey and key milestones achieved

The choice to focus on the young adult population in particular

Patient experience with SparkRx

Defining good patient engagement in adolescent mental health

Evidence generation and FDA submission process

Business hypthothesis and scaling plan

The future of the PDT market


Guest Links and Resources:

Connect with Benjamin Alouf, MD on LinkedIn


Visit Limbix.com


Episode PDF

Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix


Host Links:

Eugene Borukhovich: Twitter | LinkedIn


Chandana Fitzgerald, MD: Twitter | LinkedIn


YourCoach.health: Website | Twitter


Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram